This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In the ISCHEMIA (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches) trial, researchers examined the risk of ischemic events in patients with stable coronaryarterydisease. years, with 57.1% occurring within 30 days after CABG. Original article: Redfors B et al.
ObjectivesRevascularization in patients with severely reduced left ventricular function and coronaryarterydisease (CAD) is associated with a high perioperative risk.
BACKGROUND:Diabetes may be associated with differential outcomes in patients undergoing left main coronary revascularization with percutaneous coronary intervention (PCI) or coronaryarterybypassgrafting (CABG). 1.52]) or without (155/1634 [9.7%] versus 142/1655 [8.9%]; hazard ratio, 1.08 [95% CI, 0.86–1.36;PintHR=0.87)
Left main coronaryarterydisease (CAD) and diabetes pose significant challenges in cardiovascular care, often leading to adverse outcomes. However, the comparative long-term efficacy of percutaneous coronary intervention (PCI) versus coronaryarterybypassgrafting (CABG) in patients with these conditions remains unclear.
Introduction The presence of non-coronary atherosclerosis (NCA) in patients with coronaryarterydisease is associated with a poor prognosis. We have studied whether NCA is also a predictor of poorer outcomes in patients undergoing coronaryarterybypassgrafting (CABG).
Angiography done after initial stabilization showed severe stenosis of distal left main coronaryartery. In addition, there were multiple lesions in all three vessels, making a standard indication for an urgent coronaryarterybypassgrafting. There is minimal ST segment elevation in aVR as well.
In most cases, rather, the culprit is gross ischemia due to myocardialinfarction, cardiomyopathy, or advanced coronaryarterydisease. Unfortunately, today’s case is lacking any such diagnostics, thus I cannot say with certainty that the QT interval is, or is not, culpable in arrhythmogenesis. [1]
The patient was brought directly to the cardiac catheterization lab for PCI, bypassing the ED. The diagnostic coronary angiogram identified only minimal coronaryarterydisease, but there was a severely calcified, ‘immobile’ aortic valve. In the cath lab, the patient’s blood pressure remained low.
Introduction Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) have been linked to clinical outcomes in patients with coronaryarterydisease (CAD). However, the prognostic value of TIMP-1 in patients with CAD who underwent coronaryarterybypassgrafting (CABG) has not been elucidated.
Background:Lp(a) (lipoprotein[a]) is a highly atherogenic lipoprotein subfraction that may contribute to polygenic risk of coronaryarterydisease (CAD), but the extent of this contribution is unknown. years, 13 538 participants had incident CAD (myocardialinfarction, coronaryarterybypassgrafting, or coronary angioplasty).Results:TheLPAregion
Studies have shown that an increased left ventricular end-diastolic diameter (LVEDD) is associated with worse outcomes in various cardiovascular conditions, including heart failure, and coronaryarterydisease (CAD). The restrictive cubic spline in Figure 2 showed that LVEDD greater than 60 mm increased the risk of MACEs.
One of the most effective treatments for severe coronaryarterydisease, a type of cardiovascular disease, is coronaryarterybypassgrafting (CABG), a procedure designed to restore blood flow to the heart. But does coronaryarterybypass surgery also improve erectile capacity?
Coronaryarterybypassgrafting (CABG) is a common and effective treatment for patients with complex coronaryarterydisease. This case report discusses a 75-year-old male patient who presented with angina and shortness of breath due to thrombus formation in a venous graft 20 years after CABG.
He had undergone coronaryarterybypassgrafting due to myocardialinfarction and severe three-vessel coronaryarterydisease. Clinical introduction A man in his 80s presented to the hospital with dizziness, pre-syncope, chest tightness and palpitations for 3 days.
Angiogram: Severe two-vessel coronaryarterydisease of a left dominant system including 70 to 80% stenosis involving the distal left main/bifurcation. There is no left ventricular wall motion abnormality identified. Smith: not sure why that is. The ECG shows inferior ischemia.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content